Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Summary for Patients (PDF)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Shlipak, M. G.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

BRIEF COMMUNICATION

The Incidence of Unrecognized Myocardial Infarction in Women with Coronary Heart Disease

right arrow Michael G. Shlipak, MD, MPH; Darryl A. Elmouchi, MD; David M. Herrington, MD, MHS; Feng Lin, MS; Deborah Grady, MD, MPH; Mark A. Hlatky, MD, for the Heart and Estrogen/progestin Replacement Study Research Group

5 June 2001 | Volume 134 Issue 11 | Pages 1043-1047

Background: Several cohort studies in populations without coronary heart disease have demonstrated that up to 40% of incident myocardial infarctions are clinically unrecognized.

Objective: To determine the incidence of unrecognized myocardial infarction in women with coronary heart disease in the Heart and Estrogen/progestin Replacement Study (HERS).

Design: Randomized, double-blind, placebo-controlled trial of conjugated estrogens plus medroxyprogesterone or identical placebo with 4.1 years of follow-up.

Settings: Outpatient and community settings at 20 U.S. clinical centers.

Patients: 2763 postmenopausal women younger than 80 years of age with coronary heart disease and an intact uterus.

Measurements: Annual electrocardiograms were obtained for all participants during follow-up (mean, 4.1 years) and were evaluated by using the NOVACODE computer algorithm and visual confirmation. A total of 13 715 electrocardiograms were obtained. Suspected unrecognized myocardial infarctions were investigated by comparing a participant's previous surveillance electrocardiograms with the electrocardiograms obtained from all of her intervening hospitalizations. Characteristics of patients with recognized and unrecognized myocardial infarction were compared.

Results: Among the 256 nonfatal myocardial infarctions, 11 were unrecognized (4.3% [95% CI, 2.2% to 7.6%]). Seven occurred in women assigned to placebo and 4 occurred in women assigned to hormone therapy (P > 0.2). Women with unrecognized myocardial infarction were less likely to have diabetes mellitus or previous angina and were more likely to have had previous bypass surgery compared with women who had clinically recognized myocardial infarction.

Conclusion: The incidence of unrecognized myocardial infarction in women with coronary disease was far lower than that observed in previous studies of populations without coronary heart disease.

Author and Article Information
space

From the University of California, San Francisco, Veterans Affairs Medical Center, San Francisco, and Stanford University School of Medicine, Stanford, California; and Wake Forest University School of Medicine, Winston-Salem, North Carolina.

Grant Support: This study and the HERS trial were funded by Wyeth-Ayerst Research, Radnor, Pennsylvania. Dr. Shlipak is a recipient of the Veterans Administration Research Career Development Award (99-314-1) from the Division of Health Services Research and Development.

Requests for Single Reprints: Michael Shlipak, MD, MPH, General Internal Medicine Section (111A-1), Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, CA 94121; e-mail, shlip{at}itsa.ucsf.edu.

Current Author Addresses: Drs. Shlipak, Elmouchi, and Grady: General Internal Medicine Section (111A-1), Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, CA 94121.

Dr. Herrington: Department of Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1045.

Ms. Lin: University of California, San Francisco, Prevention Sciences Group, 74 New Montgomery Street, Suite 600, San Francisco, CA 94105.

Dr. Hlatky: Stanford University School of Medicine, HRP Redwood Building, Stanford, CA 94305-5405.

Author Contributions: Conception and design: M.G. Shlipak, D. Grady, M.A. Hlatky.

Analysis and interpretation of the data: M.G. Shlipak, D.A. Elmouchi, D.M. Herrington, F. Lin, D. Grady, M.A. Hlatky.

Drafting of the article: M.G. Shlipak, D.A. Elmouchi.

Critical revision of the article for important intellectual content: M.G. Shlipak, D.A. Elmouchi, D.M. Herrington, F. Lin, D. Grady, M.A. Hlatky.

Final approval of the article: M.G. Shlipak, D.A. Elmouchi, D.M. Herrington, F. Lin, D. Grady, M.A. Hlatky.

Provision of study materials or patients: D.M. Herrington.

Statistical expertise: F. Lin.

Obtaining of funding: D. Grady.

Administrative, technical, or logistic support: D. Grady.

Collection and assembly of data: D. Grady.


Related articles in Annals:

Summaries for Patients
Unrecognized Heart Attacks in Women with Known Coronary Artery Disease
Annals 2001 134: S11. [Full Text]  



This article has been cited by other articles:


Home page
Arch Intern MedHome page
J. G. Canto, R. J. Goldberg, M. M. Hand, R. O. Bonow, G. Sopko, C. J. Pepine, and T. Long
Symptom Presentation of Women With Acute Coronary Syndromes: Myth vs Reality
Arch Intern Med, December 10, 2007; 167(22): 2405 - 2413.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. de Torbal, E. Boersma, J. A. Kors, G. van Herpen, J. W. Deckers, D. A.M. van der Kuip, B. H. Stricker, A. Hofman, and J. C.M. Witteman
Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study
Eur. Heart J., March 2, 2006; 27(6): 729 - 736.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. C. McSweeney, M. Cody, P. O'Sullivan, K. Elberson, D. K. Moser, and B. J. Garvin
Women's Early Warning Symptoms of Acute Myocardial Infarction
Circulation, November 25, 2003; 108(21): 2619 - 2623.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
V. W. Pinn
Sex and Gender Factors in Medical Studies: Implications for Health and Clinical Practice
JAMA, January 22, 2003; 289(4): 397 - 400.
[Full Text] [PDF]


Home page
JAMAHome page
R. Glaser, H. C. Herrmann, S. A. Murphy, L. A. Demopoulos, P. M. DiBattiste, C. P. Cannon, and E. Braunwald
Benefit of an Early Invasive Management Strategy in Women With Acute Coronary Syndromes
JAMA, December 25, 2002; 288(24): 3124 - 3129.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. Grady, D. Herrington, V. Bittner, R. Blumenthal, M. Davidson, M. Hlatky, J. Hsia, S. Hulley, A. Herd, S. Khan, et al.
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)
JAMA, July 3, 2002; 288(1): 49 - 57.
[Abstract] [Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Silent MI Among Postmenopausal Women with CHD
Journal Watch Cardiology, July 20, 2001; 2001(720): 6 - 6.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2001 by the American College of Physicians.